Mar 29, 1999
Guidant Completes Federal Trade Commission Review Process

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced the completion of the government review process with the Federal Trade Commission (FTC) for its pending acquisition of the electrophysiology business from Sulzer Medica Ltd. (Swiss Stock Exchange: SMEN and NYSE: SM). Guidant anticipates completing this acquisition in the near future.

A global leader in the medical device industry, Guidant Corporation provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease. For more information on Guidant''s products and services, visit the company''s Web site at http://www.guidant.com.